| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/13/2011 | CA2727905A1 Method of altering perception of time |
| 07/12/2011 | US7977506 Amino acid for delivering active materials; bioavailability |
| 07/12/2011 | US7977369 Via 3-hydroxymethyl-5-aziridinyl-1-1-methyl-2-(1H-indole-4,7-dione )propenol |
| 07/12/2011 | US7977045 Aqueous-based pharmaceutical composition |
| 07/12/2011 | US7976879 Nutritional supplement product to suppress age-related decline in cognitive capacity and other aging functions |
| 07/12/2011 | US7976872 Method for distributing a pharmaceutically active compound in an excipient |
| 07/12/2011 | US7976871 Modified release composition of highly soluble drugs |
| 07/12/2011 | US7976870 using a sustained release oral dosage form of a therapeutically effective amount of the drug such as minocycline hydrochloride incorporated in a matrix of biocompatible, hydrophilic polymer of specified swelling properties and erosion rate |
| 07/12/2011 | US7976869 Fenofibrate tablets |
| 07/12/2011 | US7976868 Liposomes comprising duramycin and anti-viral agents |
| 07/12/2011 | US7976867 Multilayer; backing layer containing reservoir, covering with aperture , adhesive and lining |
| 07/12/2011 | US7976865 Medical tape preparation |
| 07/12/2011 | US7976864 Film preparation and process for preparing the same |
| 07/12/2011 | US7976863 Bonding synthetic antimicrobial cationic peptide to medical device using coupling agent; polymerizing (meth)acryloyl polpeptide comprising melimine and/or protattin; catheters, contact lenses, stents, bags, tubes, bandages; ophthalmology |
| 07/12/2011 | US7976862 Longitudinal body; polymeric coating of polyalkyl(meth)acrylate and/or aromatic poly(meth)acrylate; and poly(ethylene-co-vinyl acetate); triamcinolone acetonide; drug delivery to eye |
| 07/12/2011 | US7976860 A porous protein matrix with a structural component partly or fully anchored in the matrix; at least one surface has a protein membrane crosslinked with the matrix; sufficient stability with improved flexibility, biocompatibility and absorption; vascular prosthetics |
| 07/12/2011 | US7976859 Implant filling material and method |
| 07/12/2011 | US7976858 Sustained intra-articular release; synovial fluid |
| 07/12/2011 | US7976853 Process for producing coated preparation |
| 07/12/2011 | US7976850 Pox viridae treatment |
| 07/12/2011 | US7976847 Congestive heart failure; antiischemic agents; administering calcitonin gene related peptide in thermoplastic biocompatible polymer; controlled release or maintenance therapy |
| 07/12/2011 | US7976834 For example, glycerol initiated multiarm polyethylene glycol modified with a polypeptide and then conjugated to a drug such as 5-fluorouracil; high drug-carrying capability; useful for hydrophilic and charge-bearing drugs as well |
| 07/12/2011 | US7976826 Compositions and methods relating to prevention of chemotherapy-induced alopecia |
| 07/12/2011 | US7976825 Cancer cell diagnosis by targeting delivery of nanodevices |
| 07/12/2011 | US7976823 Ferromagnetic particles and methods |
| 07/12/2011 | US7976743 drug deliverying nitric oxide containing liposomes for hyperplasia, atherosclerosis; drug conjugated with antibody for drug target at specific cells; delivery rosiglitazone; reduce side effect; freezing under pressure |
| 07/12/2011 | US7976535 Method for control of the volume flux of a liquid in an osmotic micropump and osmotic micropump |
| 07/12/2011 | US7976534 Event triggered infection monitoring |
| 07/12/2011 | US7976520 Eye wall anchored fixtures |
| 07/12/2011 | US7975690 Nasal devices |
| 07/12/2011 | CA2576392C Ocular implant made by a double extrusion process |
| 07/12/2011 | CA2563816C New hydroxapatite calcium phosphates, their method of preparation and their applications |
| 07/12/2011 | CA2549498C A soft capsule of butylphthalide and a process for preparing the same |
| 07/12/2011 | CA2524806C Highly plastic granules for making fast melting tablets |
| 07/12/2011 | CA2501245C Method for producing solid galenic formulations using a crosslinked non-thermoplastic carrier |
| 07/12/2011 | CA2493881C Rapidly soluble film-shaped preparation |
| 07/12/2011 | CA2483097C Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass |
| 07/12/2011 | CA2481268C Medicaments comprising steroids and a novel anticholinergic |
| 07/12/2011 | CA2475704C Colonic release formulations of prednisolone sodium metasulphobenzoate coated with amylose, ethyl cellulose and dibutyl sebacate |
| 07/12/2011 | CA2472967C Film-shaped or wafer-shaped pharmaceutical preparation with masked taste |
| 07/12/2011 | CA2458455C Pharmaceutical compositions comprising colloidal silicon dioxide |
| 07/12/2011 | CA2454389C Solid composition containing bacillus-type non-pathogenic bacterial spores |
| 07/12/2011 | CA2441744C Formulations containing propofol and a sulfoalkyl ether cyclodextrin |
| 07/12/2011 | CA2440610C Induction of tumor immunity by variants of folate binding protein |
| 07/12/2011 | CA2408956C Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 07/12/2011 | CA2406570C Dermal compositions containing coenzyme q as the active ingredient |
| 07/12/2011 | CA2396744C Synthetic lipid-a analogs and uses thereof |
| 07/12/2011 | CA2373972C Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 07/12/2011 | CA2362927C Novel albumin-free factor viii formulations |
| 07/12/2011 | CA2349342C Manganese compositions and methods for mri |
| 07/07/2011 | WO2011082432A1 Multifunctional degradable nanoparticles with control over size and functionalities |
| 07/07/2011 | WO2011082369A2 Injectable formulations for parenteral administration |
| 07/07/2011 | WO2011082355A1 Treatment of leigh syndrome and leigh-like syndrome with tocotrienol quinones |
| 07/07/2011 | WO2011082283A2 Management of myoclonus with oral liposomal reduced glutathione |
| 07/07/2011 | WO2011081772A1 Systems and methods for anesthetizing ear tissue |
| 07/07/2011 | WO2011081672A1 Low toxicity topical active agent delivery system |
| 07/07/2011 | WO2011081628A1 Melt extruded nicotine thin strips |
| 07/07/2011 | WO2011081625A1 Melt extruded thin strips containing coated pharmaceutical actives |
| 07/07/2011 | WO2011081556A1 Composition containing 6-decaprenyl-2,3-dimethoxy-5-methyl-1,4 -benzoquinone for parenteral delivery and method for producing same |
| 07/07/2011 | WO2011081443A2 Target-aiming drug delivery system for diagnosis and treatment of cancer containing liposome labeled with peptides which specifically targets interleukin-4 receptors, and manufacturing method thereof |
| 07/07/2011 | WO2011081430A2 Polymer nanoparticle injection formulation composition containing rapamycin with improved water solubility, preparation method thereof, and anticancer composition for combined use with radiotherapy |
| 07/07/2011 | WO2011081253A1 Injectable porous microparticle filler system |
| 07/07/2011 | WO2011081221A1 Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction |
| 07/07/2011 | WO2011081199A1 Oral preparation having improved quality |
| 07/07/2011 | WO2011081118A1 Pharmaceutical composition for oral administration |
| 07/07/2011 | WO2011081117A1 Solid pharmaceutical composition for oral administration |
| 07/07/2011 | WO2011081017A1 Adhesive tape preparation |
| 07/07/2011 | WO2011080984A1 Therapeutic agent (y - 39983 ) for corneal endothelial dysfunction |
| 07/07/2011 | WO2011080741A2 Core stabilized microcapsules, method of their preparation and uses thereof |
| 07/07/2011 | WO2011080716A2 Pharmaceutical composition for modified delivery of actives |
| 07/07/2011 | WO2011080706A1 Enhanced solubility of ziprasidone |
| 07/07/2011 | WO2011080704A1 Producing stable adefovir dipivoxil solid dispersions in amorphous state |
| 07/07/2011 | WO2011080683A1 Taste masked dosage forms of bitter tasting anti-retroviral drugs |
| 07/07/2011 | WO2011080502A2 New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
| 07/07/2011 | WO2011080501A2 New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
| 07/07/2011 | WO2011080500A2 New pharmaceutical dosage form for the treatment of gastric acid-related disorders |
| 07/07/2011 | WO2011080438A1 Porcine seminal material composition for artificial insemination of sows |
| 07/07/2011 | WO2011080413A1 Enhanced bioavailability solid oral pharmaceutical composition containing a biphosphonic acid or one of the salts thereof |
| 07/07/2011 | WO2011080346A2 Pellets and microparticles of pravastatin sodium and a process of making them |
| 07/07/2011 | WO2011080342A1 Administration route for a composition to protect an animal against rhodococcus equi |
| 07/07/2011 | WO2011080246A1 Oral liquid pharmaceutical composition of nifedipine |
| 07/07/2011 | WO2011080148A2 An aqueous intravenous nanosuspension with reduced adverse effects |
| 07/07/2011 | WO2011080141A2 Degradable removable implant for the sustained release of an active compound |
| 07/07/2011 | WO2011080080A1 COMPOSITION COMPRISING NANOPARTICLES OF TiO2 |
| 07/07/2011 | WO2011079768A1 Production method of solid preparation and the preparation produced by the method |
| 07/07/2011 | WO2011079767A1 Solid formulation of zopiclone and the preparation method thereof |
| 07/07/2011 | WO2011079766A1 Aripiprazole solid preparation and the production method thereof |
| 07/07/2011 | WO2011079764A1 Solid formulation of eszopiclone and the preparation method thereof |
| 07/07/2011 | WO2011079609A1 Preparation method of solid formulations and solid formulations prepared thereby |
| 07/07/2011 | WO2011079608A1 Preparation method of solid formulations and solid formulations prepared thereby |
| 07/07/2011 | WO2011079410A1 Medicinal composition including sunflower extract, preparative method and use thereof |
| 07/07/2011 | WO2011079372A1 Therapeutic agent delivery apparatus and process |
| 07/07/2011 | WO2011079356A1 Carbon nanotube conjugate for inhibiting pathogenic infection structures in plants |
| 07/07/2011 | WO2011057714A3 Method for preventing the crystallisation of pharmaceuticals in a polymer film |
| 07/07/2011 | WO2011056487A3 Stable thickener formulations |
| 07/07/2011 | WO2011055156A3 Pharmaceutical compositions comprising an estrogen, a gestagen and various copolymers |
| 07/07/2011 | WO2011031561A3 Nucleic acid molecules and uses thereof |
| 07/07/2011 | WO2011028799A3 Ganglioside transmucosal formulations |
| 07/07/2011 | WO2011018636A3 Photochemical internalization method |
| 07/07/2011 | WO2011018635A3 Photosensitizing compositions |